Savara (SVRA) Introduces aPAP ClearPath
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Savara Introduces aPAP ClearPath™, a GM-CSF Autoantibody Blood Test to Detect Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
December 21, 2023 8:05 AM ESTThe simple, no-cost, and noninvasive test is now available to physicians in the U.S. Company launches campaign in the U.S. to raise awareness of the rare autoimmune lung disease and need for early testing
LANGHORNE, Pa.--(BUSINESS WIRE)-- Savara Inc. (Nasdaq:... More



